全文获取类型
收费全文 | 52587篇 |
免费 | 4225篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 507篇 |
儿科学 | 1916篇 |
妇产科学 | 1362篇 |
基础医学 | 6672篇 |
口腔科学 | 510篇 |
临床医学 | 6717篇 |
内科学 | 9278篇 |
皮肤病学 | 1088篇 |
神经病学 | 5585篇 |
特种医学 | 1106篇 |
外科学 | 5682篇 |
综合类 | 484篇 |
现状与发展 | 1篇 |
一般理论 | 88篇 |
预防医学 | 7235篇 |
眼科学 | 929篇 |
药学 | 3638篇 |
中国医学 | 85篇 |
肿瘤学 | 4038篇 |
出版年
2024年 | 50篇 |
2023年 | 478篇 |
2022年 | 711篇 |
2021年 | 1855篇 |
2020年 | 1139篇 |
2019年 | 1836篇 |
2018年 | 1946篇 |
2017年 | 1492篇 |
2016年 | 1582篇 |
2015年 | 1677篇 |
2014年 | 2356篇 |
2013年 | 3093篇 |
2012年 | 4625篇 |
2011年 | 4549篇 |
2010年 | 2495篇 |
2009年 | 2072篇 |
2008年 | 3605篇 |
2007年 | 3565篇 |
2006年 | 3340篇 |
2005年 | 3140篇 |
2004年 | 2698篇 |
2003年 | 2282篇 |
2002年 | 1983篇 |
2001年 | 333篇 |
2000年 | 270篇 |
1999年 | 328篇 |
1998年 | 347篇 |
1997年 | 267篇 |
1996年 | 228篇 |
1995年 | 205篇 |
1994年 | 148篇 |
1993年 | 127篇 |
1992年 | 174篇 |
1991年 | 143篇 |
1990年 | 179篇 |
1989年 | 160篇 |
1988年 | 130篇 |
1987年 | 128篇 |
1986年 | 105篇 |
1985年 | 121篇 |
1984年 | 107篇 |
1983年 | 96篇 |
1982年 | 58篇 |
1981年 | 60篇 |
1980年 | 48篇 |
1979年 | 58篇 |
1978年 | 65篇 |
1976年 | 42篇 |
1975年 | 44篇 |
1973年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Jay Jegathesan Jennifer A Liebenthal Melinda G Arnett Richard L Clancy Janet D Pierce 《Medsurg nursing》2004,13(6):371-375
Advances in science have increased the knowledge of how cells die in the body (apoptosis). A basic understanding of this process can improve nurses' ability to review new scientific literature and enable them to provide safer bedside care. 相似文献
102.
Jennifer S. Singer Robert B. Ettenger John L. Gore H. Albin Gritsch Jacob Rajfer J. Thomas Rosenthal Peter Schulam 《American journal of transplantation》2005,5(10):2514-2520
Despite reports demonstrating the safety of laparoscopic donor nephrectomy (LDN) for pediatric recipients of renal transplants, recent evidence has challenged using LDN for recipients 5 years of age or younger. We retrospectively reviewed the records of all pediatric recipients of living donor renal transplants from September 2000 through August 2004. We compared those who received allografts recovered by LDN (n = 34) with those recovered by open donor nephrectomy (ODN, n = 26). Outcomes of interest included operative complications, postoperative renal function, the incidence of delayed graft function or episodes of acute rejection and long-term graft function. Donor and recipient demographic data were similar for the LDN and ODN groups. Serum creatinine and calculated creatinine clearance were not significantly different between groups both in the early postoperative period and at long-term follow-up (p > 0.142). Rates of delayed graft function and acute rejection did not differ between groups. Among recipients aged 5 years old or younger stratified by donor technique (9 LDN, 5 ODN recipients), no difference was noted in graft outcomes both early and long-term (p > 0.079). At our center, pediatric LDN recipients have graft outcomes comparable to those of ODN recipients. At experienced centers, we recommend continued use of LDN for pediatric recipients of all ages. 相似文献
103.
Hasan F Batirel Saime Batirel Richard N Mitchell Scott J Swanson 《The Journal of heart and lung transplantation》2005,24(6):658-664
BACKGROUND: Interferon-gamma, produced by T-helper cells, activates macrophages and increases expression of major histocompatibility complex (MHC) products in acute and chronic rejection. We investigated the role of interferon-gamma in murine heterotopic tracheal allografts. METHODS: Tracheas from BALB/c mice were heterotopically transplanted to BALB/c (12 isografts: 2 weeks [n = 6] and 4 weeks [n = 6], C57BL/6 (12 allografts: 2 weeks [n = 6] and 4 weeks [n = 6]) and C57BL/6 interferon-gamma knockout mice (12 interferon-gamma knockout allografts: 2 weeks [n = 4] and 4 weeks [n = 8]). BALB/c interferon-gamma knockout tracheas were transplanted to C57BL/6 mice (reverse knockout: 4 weeks [n = 6]) and BALB/c interferon-gamma knockout mice (4 weeks [n = 2]). C57BL/6 tracheas were transplanted to Bm12 mice (MHC Class II mismatch allografts: 4 weeks [n = 6]). Conventional histology and immunohistochemistry for CD4, CD8 and CD11b were performed. RESULTS: Minimal (<20%) obliteration was seen at 2 weeks in the allograft groups. No obliteration was seen in the isograft groups. However, all allografts were completely obliterated at 4 weeks. Interferon-gamma knockout allograft combinations displayed severe rejection characterized by intense intra- and extraluminal infiltration by CD4-, CD8- and CD11b-labeled cells. The MHC Class II mismatch allograft group showed normal epithelium and mild sub-epithelial infiltration by CD4+ cells at 4 weeks (CD8-, CD11b-). CONCLUSIONS: Absence of interferon-gamma does not protect the allograft from obliteration. Epithelial destruction by cytotoxic T cells appears to be an important mechanism in the development of obliteration in murine heterotopic tracheal allografts. 相似文献
104.
Liesbeth Vandenput Fernand Labrie Dan Mellstr?m Charlotte Swanson Thomas Knutsson Ralph Peeker Osten Ljunggren Eric Orwoll Anna L Eriksson Jan-Erik Damber Claes Ohlsson 《Journal of bone and mineral research》2007,22(2):220-227
Androgens are important regulators of bone and prostate health in elderly men. The role of serum levels of glucuronidated androgen metabolites as predictors of BMD and prostate volume in men is unclear. We show that specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. INTRODUCTION: Androgens are important regulators of bone and prostate health in elderly men. Local synthesis and degradation of androgens are likely to be important parameters of biological action of androgens in androgen-responsive tissues. The aim of this study was to determine the role of serum levels of glucuronidated androgen metabolites as predictors of BMD and prostate volume in elderly men. MATERIALS AND METHODS: A subsample of the population-based Swedish part of the MrOS study (n = 631, average age = 75.9 years) was investigated. Bone parameters were measured using DXA. Serum levels of total testosterone (T) and dihydrotestosterone (DHT) were measured by gas chromatography/mass spectroscopy (GC-MS); androstane-3alpha,17beta-diol-3glucuronide (3G) and androstane-3alpha,17beta-diol-17glucuronide (17G) were measured by liquid chromatography/mass spectroscopy. Prostate volume (n = 159) was measured by transrectal ultrasound. RESULTS: The general pattern is that two of the glucuronidated androgen metabolites, namely 17G and 3G, are stronger positive predictors of BMD than the bioactive androgens (T and DHT). In addition, 17G is a clear positive predictor of prostate volume, explaining 4.5% of the variance in prostate volume, whereas the bioactive androgens do not display any association with prostate volume. CONCLUSIONS: Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. Future studies should determine if the glucuronidated androgen metabolites also reflect other biological correlates of androgenic activity, including prostate cancer, and if low levels might be a marker of general androgen deficiency in men. 相似文献
105.
106.
107.
Objective. To determine the stability of an admixture combining ziconotide with bupivacaine hydrochloride during simulated intrathecal infusion under laboratory conditions at 37°. Materials and Methods. An admixture containing ziconotide (25 µg/mL) and bupivacaine hydrochloride (5 mg/mL) was stored in SynchroMed® II pumps at 37° and in control vials at either 37° or 5°. Using high‐performance liquid chromatography, drug concentrations were determined from samples obtained at varying intervals during the 30‐day study. Results. After 30 days, pump ziconotide and bupivacaine hydrochloride concentrations measured an average of 86.9% and 99.4% of their initial concentrations, respectively. Control vials displayed similar degradation rates for both drugs. Statistical evaluation of the ziconotide 95% confidence interval indicated that the ziconotide concentration would meet or exceed 90% and 80% of initial concentration for 22 days and 45 days, respectively. Conclusions. An admixture containing 25 µg/mL ziconotide and 5 mg/mL bupivacaine hydrochloride was 90% stable for 22 days and 80% stable for 45 days (extrapolated) in SynchroMed® II infusion pumps. 相似文献
108.
109.
110.